SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-224870
Filing Date
2012-05-10
Accepted
2012-05-10 13:58:32
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d321556d10q.htm 10-Q 677215
2 LONG-TERM INCENTIVE PLAN UNDER 2010 STOCK OPTION AND INCENTIVE PLAN d321556dex101.htm EX-10.1 8822
3 SECTION 302 CEO CERTIFICATION d321556dex311.htm EX-31.1 10061
4 SECTION 302 CFO CERTIFICATION d321556dex312.htm EX-31.2 10082
5 SECTION 906 CEO CERTIFICATION d321556dex321.htm EX-32.1 4318
6 SECTION 906 CFO CERTIFICATION d321556dex322.htm EX-32.2 4339
  Complete submission text file 0001193125-12-224870.txt   2148453

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aegr-20120331.xml EX-101.INS 240126
8 XBRL TAXONOMY EXTENSION SCHEMA aegr-20120331.xsd EX-101.SCH 10279
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20120331_cal.xml EX-101.CAL 39876
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20120331_lab.xml EX-101.LAB 123201
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20120331_pre.xml EX-101.PRE 73746
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 12829404
SIC: 2834 Pharmaceutical Preparations